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Harmonizing clinical pharmacology and therapeutics (CPT) education in Europe is necessary to ensure that the prescribing
competency of future doctors is of a uniform high standard. As there are currently no uniform requirements, our aim was to
achieve consensus on key learning outcomes for undergraduate CPT education in Europe. We used amodified Delphi
method consisting of three questionnaire rounds and a panel meeting. A total of 129 experts from 27 European countries
were asked to rate 307 learning outcomes. In all, 92 experts (71%) completed all three questionnaire rounds, and 33
experts (26%) attended themeeting. 232 learning outcomes from the original list, 15 newly suggested and 5 rephrased
outcomes were included. These 252 learning outcomes should be included in undergraduate CPT curricula to ensure that
European graduates are able to prescribe safely and effectively. We provide a blueprint of a European core curriculum
describing when and how the learning outcomesmight be acquired.
Study Highlights
WHAT IS THE CURRENT KNOWLEDGE ON THE
TOPIC?
 A recent study showed that the prescribing competencies of
final-year medical students in Europe were poor, resulting in
many potentially harmful prescribing errors. Another recent
study showed marked variation in the quantity and quality of
CPT education within and between European countries. Har-
monizing CPT education at a European level might improve
the prescribing competencies of future doctors, but to date
there is no consensus on the required learning outcomes for
European graduates in order to prescribe safely and effectively.
WHAT QUESTION DID THIS STUDY ADDRESS?
 In this modified Delphi study, key learning outcomes were
identified for teaching and assessing CPT in undergraduate
medical curricula in Europe.
WHAT THIS STUDY ADDS TO OUR KNOWLEDGE
 A large European expert panel reached consensus on 252
key learning outcomes that should be included in undergrad-
uate CPT curricula to ensure that European graduates are
able to prescribe safely and effectively. Additionally, we pro-
vide a blueprint of a European core curriculum in CPT
describing when and how the learning outcomes might be
taught and assessed during the undergraduate medical
curriculum.
HOW THIS MIGHT CHANGE CLINICAL PHARMA-
COLOGY OR TRANSLATIONAL SCIENCE
 A European core curriculum in CPT might help to harmo-
nize CPT education and improve the prescribing competencies
of future European doctors and thereby patient safety.
Prescribing is a complex and challenging task for every medical
graduate. Poor prescribing may result in medication errors and
adverse drug reactions, with potential consequences for patient
safety and healthcare costs.1,2 In many European countries,
recently graduated doctors write a large proportion of
prescriptions in hospitals, often with minimal supervision from
senior clinicians. In order to prescribe safely and effectively at the
start of their professional careers, medical graduates should have
acquired appropriate prescribing competencies (i.e., knowledge,
skills, and attitudes). Unfortunately, studies throughout Europe
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suggest that medical students have not acquired these necessary
competencies by the time they graduate. In the UK and the
Netherlands, recent graduates were found to be responsible for a
large number of prescribing errors and reported having little con-
fidence in their prescribing skills.3–6 In other European countries,
there are similar concerns about a lack of prescribing competen-
cies among medical graduates.7 A recent multicenter study showed
a general lack of essential prescribing competencies among 895
final-year medical students from 17 European medical schools.8
This is even more worrying, since the demands on new prescribers
are increasing progressively because of several trends, including a
growing number of medicines, increasingly vulnerable patients,
and more complicated regimens due to polypharmacy and
multimorbidity.9
Poor education in clinical pharmacology and therapeutics
(CPT) during the undergraduate medical curriculum may under-
lie the lack of prescribing competencies among recent graduates.
Indeed, most final-year students of European medical schools felt
that their medical curriculum had not adequately prepared them
for safe prescribing and thought that too little time had been
devoted to CPT.8 Moreover, a recent study showed there was a
marked variation in the quantity and quality of CPT education
in European medical schools.10 In most schools, both teaching
and assessment are mainly based on traditional learning methods
(e.g., lectures and written examinations), which seem to be associ-
ated with a lower level of prescribing knowledge and skills among
final-year students compared with problem-based learning meth-
ods (e.g., patient simulation and real-life prescribing).8 Moderniz-
ing and harmonizing CPT education at a European level might
prevent and reduce prescribing errors in the future, thereby
improving patient safety. Furthermore, harmonization is becom-
ing more important, given the increased mobility of medical stu-
dents and junior doctors across Europe.11
A first step toward harmonization is to establish which learn-
ing outcomes should be common to all European undergraduate
CPT curricula, as suggested by the British Pharmacological Soci-
ety (BPS) and the European Association for Clinical Pharmacol-
ogy and Therapeutics (EACPT) in 2007.7 Defining clear
learning outcomes might also help to shape and strengthen the
CPT specialty in Europe, since it has lost ground in recent deca-
des and has become increasingly invisible in medical curricula.12
Previous studies of CPT learning outcomes have mostly come
from the UK,9,13–15 the Netherlands,16 and Sweden.17 To date,
there has been no clear and robust definition of what European
medical graduates should know about CPT in order to prescribe
safely and effectively. Therefore, on behalf of the Education
Working Group of the EACPT, we conducted this modified
Delphi study to reach consensus on key learning outcomes for
teaching and assessing CPT during the undergraduate medical
training in Europe.
RESULTS
In total, 129 (129/177; 73%) experts from 27 European coun-
tries accepted the invitation and formed the consensus panel.
Their characteristics are presented in Table S1. The response
rate was 85% (109/129), 74% (95/129), 81% (104/129) for
Rounds 1, 2, and 3, respectively. Ninety-two experts (71%) from
25 European countries completed all three rounds (79 doctors,
nine pharmacists, and four scientists). The average educational
experience of all panelists was 17.5 years (range 3–38); 78% of
the medical doctors were clinical pharmacologists. Thirty-three
panelists (26%) from 17 European countries attended the face-
to-face meeting (Table S1).
Delphi process
The flow chart of the systematic literature search is shown in
Figure 1. The articles identified in the literature search are pre-
sented in Table S2. During Round 1, 226 of the 307 outcomes
were included; 81 outcomes for which there was no consensus
about their relevance, 24 new outcomes, and two adapted out-
comes were resubmitted in Round 2. During Round 2, 18 of the
107 resubmitted outcomes were included, 73 were excluded, and
16 were selected for discussion during the panel meeting (75–
80% agreement). During the panel meeting, 5 of the 16 outcomes
were included, six were excluded, and five were adapted and
resubmitted in Round 3. In this round, three of the five adapted
Figure 1 Flowchart of the systematic literature search.
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Table 1 Subcategories of learning outcomes that were included (n5 34)
Competence Subcategory (n5 34)
Number of learning
outcomes (n5 252)
Knowledge 1. Introduction to clinical pharmacology and therapeutics
1.1 Basic principles
1.2 Drugs in healthcare and society
5
2. Pharmacodynamics
2.1 Mechanism of action
2.2 Dose-response relationships
12
3. Pharmacokinetics
3.1 Drug absorption, distribution, metabolism and excretion
3.2 Concentration–time relationships
3.3 Repeated drug dosing
21
4. Individual variability in the response to drugs
4.1 Basic principles
4.2 Pharmacokinetic variability
4.3 Pharmacogenetic variability
11
5. Adherence, compliance, and concordance
5.1 Adherence and compliance
5.2 Concordance
8
6. Therapeutic drug monitoring
6.1 Basic principles
6.2 Using drug effect and concentration
10
7. Adverse drug reactions
7.1 Basic principles
7.2 Drug allergy
7.3 Diagnosis, management and prevention
7.4 Pharmacovigilance
17
8. Drug interactions and contraindications
8.1 Interactions
8.2 Contraindications
11
9. Medication errors 4
10. Drug discovery, development and regulation
10.1 Drug discovery and development
10.2 Drug regulation
7
11. Medicines management
11.1 National and local processes
11.2 Formularies and guidelines
7
12. Evidence-based prescribing
12.1 Basic principles
12.2 Critical appraisal of clinical studies
12.3 Find reliable information about drugs
12
13. Legal and ethical aspects of prescribing
13.1 Legal aspects
13.2 Ethical aspects
10
14. Prescribing for patient with special requirements
14.1 Elderly patients
14.2 Impaired liver function
14.3 Impaired renal function
14.4 Pregnant women and women of childbearing potential
14.5 Lactation
14.6 Children
29
15. Rational prescribing
15.1 Rational approach to prescribing
15.2 Dose selection
6
16. Clinical toxicology 6
17. Misuse of drugs 2
Table 1 Continued on next page
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outcomes were included, giving a total of 252 outcomes (34 sub-
categories; 192 knowledge, 47 skills, and 13 attitudes) considered
important for CPT education in Europe. The subcategories are
shown in Table 1 and the detailed learning outcomes are listed
in Tables S3–5. Most panelists indicated that 201 of the 252
included outcomes (80%) should be acquired during the clinical
years of the undergraduate medical curriculum, 33 (13%) out-
comes should be acquired during the preclinical years, and 18
(7%) during both phases (Table S3–5). Although most of the
included outcomes focused on knowledge (76%), outcomes
regarding prescribing skills and attitudes were generally consid-
ered more important (Figure 2). Sixty-three outcomes did not
meet the 80% agreement cutoff and were excluded (47 knowl-
edge, 14 skills, and 2 attitudes).
DISCUSSION
In this study, an international panel of experts identified 252 key
learning outcomes for CPT education in European medical
schools. These learning outcomes provide a detailed description
of competencies that European medical graduates should have
acquired in order to prescribe safely and effectively. To our
knowledge, this is the first Delphi study to establish CPT learn-
ing outcomes at a European level. Previous studies of CPT learn-
ing outcomes that used the Delphi technique were mainly
focused on the local setting in a specific country.14,15,17 Our Del-
phi study provides additional information that builds on earlier
CPT curricula,9,13,15,18 and offers a detailed framework for teach-
ing and assessing CPT in European medical curricula, which
could also be useful elsewhere (e.g., USA). Implementing the
identified learning outcomes in already overcrowded medical cur-
ricula will be challenging but essential in order to improve the
prescribing competencies of future European doctors and thereby
patient safety.
Perhaps not surprisingly, most of the included learning out-
comes (76%) focused on knowledge of basic and clinical pharma-
cology. This is probably because the initial list of outcomes
consisted primarily of knowledge outcomes (76%) and because
CPT education in Europe is still mainly focused on teaching theo-
retical knowledge (e.g., lectures, written exams) instead of skills
(e.g., completing drug prescriptions) and attitudes (e.g., communi-
cation with patients).10 However, this does not necessarily mean
that knowledge of basic and clinical pharmacology is more impor-
tant than skills and attitudes related to pharmacotherapy. On the
contrary, prescribing skills and attitudes were generally considered
more important (Figure 2), and these should be taught through-
out the medical curriculum because they are highly complex cog-
nitive processes that require repeated training.19 Interestingly,
most panelists indicated that skills and attitudes should be
acquired during the clinical years (years 4–6), and not the preclin-
ical years of medical training, probably because this reflects the sit-
uation in their own curriculum. Since the training of prescribing
skills during the early years of medical education has been shown
to improve students’ ability to prescribe rationally during later
years,20,21 prescribing should be taught as early as possible in the
curriculum, preferably using simulated and clinical environments
with real responsibility for patient care.13,22
Table 1 Continued
Competence Subcategory (n5 34)
Number of learning
outcomes (n5 252)
18. Complementary and alternative medicine 2
19. Use of antibiotics and antibiotic resistance 4
20. Commonly used drugs and high risk medicines 8
Skills 21. Medication history taking 7
22. Rational prescribing 11
23. Drug dose calculation 3
24. Prescription writing 4
25. Nondrug therapy 1
26. Communication 5
27. Reviewing prescriptions 3
28. Adverse drug reactions 4
29. Clinical toxicology 2
30. Obtaining information from guidelines and protocols to support prescribing 3
31. Monitoring medication 4
Attitudes 32. Risk–benefit analysis 7
33. Recognizing personal limitations in knowledge 1
34. Recognition of a balanced approach to the introduction of new drugs 5
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In contrast to previous studies,9,13,15,18 in this study the panel-
ists considered knowledge about drug marketing, development of
drug formularies and guidelines, and complementary and alterna-
tive medicines less important, on the basis that these topics are
not directly relevant for prescribing in daily clinical practice or
are usually covered by other courses in the curriculum. Similarly,
they considered preparing and administering drugs (e.g., intrave-
nous, intramuscular) less important because this role has been
taken over by nurses and pharmaceutical assistants in many Euro-
pean countries.
The CPT learning outcomes should be considered in associa-
tion with a relevant list of core drugs (“student formulary”) and
their associated therapeutic problems. These lists may help to pri-
oritize learning and avoid overburdening medical students with
facts.9 However, only a small proportion of European medical
schools (4%) use these lists in their CPT programs.10 This might
be because it takes time and effort to develop a valid list, and this
might be a problem for medical schools with a limited number of
CPT teachers. A potential solution is to develop a European list
of core drugs and diseases that European medical students should
know about by the time they graduate, as previously suggested by
the EACPT.7 In 2002, Orme et al. published a European list of
core drugs and diseases, but this probably requires updating.23
There are two prerequisites for the successful implementation
of learning outcomes. First, since CPT is often integrated in dif-
ferent courses throughout the medical curriculum, it is important
that outcomes are compatible with the learning environment and
assessment activities (constructive alignment).24 Coherence between
assessment, teaching strategies, and intended learning outcomes is
important for successful introduction of outcomes and stimulates
students to achieve high grades.25 Currently, CPT learning out-
comes in most European medical schools are not adequately aligned
with the curriculum content,10 making this requirement even more
important. Second, the purpose of introducing learning outcomes is
solely to direct teaching and students’ learning, and this should be
clearly communicated to medical students and teachers. Using out-
comes for policy and management activities may weaken their func-
tion, reducing their potential value.26
Strengths and limitations
The consensus panel in our study consisted of a large number of
experts (n5 129) from various professional backgrounds and
with different levels of educational experience, and represented
most European countries. Moreover, the overall response rate
was good in comparison with that of other studies, highlighting
the perceived importance of this topic in Europe. However, there
were also several limitations. First, due a limited time frame, not
all outcomes without 80% agreement could be discussed during
the 2-h panel meeting. Therefore, only the most critical outcomes
(75–80% agreement) were selected for discussion. Second, since
we based our list of learning outcomes only on articles published
in peer-reviewed journals, we may have missed valuable informa-
tion from nonpeer-reviewed articles such as reports published by
educational and pharmacological societies. Third, only 26% of
the panelists attended the face-to-face meeting. Although this is a
relatively small proportion, the group represented most partici-
pating European countries and was large enough to provide a reli-
able consensus.27 Lastly, there was a poor response from junior
doctors. This was most likely due to the time involved in partici-
pating in the questionnaire rounds.
Conclusion and recommendations
A large European expert panel reached consensus on 252 learning
outcomes that should be included in undergraduate CPT curric-
ula to ensure that European medical graduates are able to pre-
scribe safely and effectively. Since CPT is a dynamic specialty
that is subject to continual change, the identified learning
Figure 2 Total number of learning outcomes per subcategory (n534) for knowledge (blue; n5192), skills (yellow; n547), and attitudes (green;
n513). The red line demonstrates the mean % “(very) important” per subcategory (calculated by dividing the total % “(very) important” per subcategory
by the number of outcomes within that subcategory). TDM, Therapeutic Drug Monitoring.
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outcomes should be reviewed and revised periodically by a Euro-
pean group of CPT teachers.
In order to help medical schools to implement the identified
learning outcomes, we provide a blueprint of an integrated
context-based learning European core curriculum in CPT
describing when and how the outcomes might be taught and
assessed during the early and later years of the medical curriculum
(Figure 3). This blueprint describes the subcategories of the iden-
tified learning outcomes (Table 1) together with useful teaching
and assessment methods that have been successful at various med-
ical schools. Context-based learning refers to learning in the set-
ting that is the same or as similar as possible to the setting of the
future profession; for medical students, that is clinical practice.
CPT should be integrated longitudinally as a recurrent theme in
modules and attachments throughout the medical curriculum,
starting as early as possible. We believe that students might
acquire a better understanding of CPT if it is frequently repeated
in different modules over several study years compared to one or
two distinct courses. In the early years of the medical curriculum
(i.e., years 1–3 in Europe, and years 1–2 in the USA), the empha-
sis lies on gaining knowledge of basic and clinical pharmacology
(e.g., lectures, E-learning), while simultaneously learning to apply
this knowledge by training prescribing skills in controlled (e.g.,
case-based discussions) and simulated (e.g., role-playing sessions)
environments. In the later years (i.e., years 4–6 in Europe, and
years 3–4 in the USA), as knowledge increases, more emphasis is
given to training prescribing skills in clinical environments (e.g.,
real-world prescribing, pre-prescribing seminars), while the acqui-
sition of knowledge diminishes. During the early and later years,
most of the teaching time should be devoted to the teaching and
training of prescribing skills and attitudes, since these are highly
complex. To ensure that all relevant outcomes have been
achieved, there should be a robust and separate CPT assessment
structure, with no compensatory mechanism. Computer-based
assessments are useful for testing the knowledge, judgment, and
skills of large cohorts of students, since they are relatively quick
and easy to mark. Moreover, objective structured clinical exami-
nations are useful to assess the prescribing skills in the early years
of the medical curriculum, whereas workplace-based assessments
are preferred in the later years. The development of students’ atti-
tudes can be evaluated using a portfolio. At or near the end of
the medical curriculum, there should be a valid and reliable sum-
mative (national) assessment such as the UK Prescribing Safety
Assessment28 or Dutch National Pharmacotherapy Assessment29
to assess whether medical graduates are able to prescribe safely
and effectively. One or more individuals, preferably clinical phar-
macologists, should be responsible for coordinating all teaching
and assessment activities throughout the curriculum. Since the
proposed blueprint is resource-intensive, clinical pharmacologists
can and should not work on this alone. Teaching and assessment
can be devolved to many other teachers throughout the course,
often with organ-based specialties. Also, “near-peer” education
(e.g., junior doctors, medical students) might be helpful to reduce
the workload of the usually small group of CPT teachers. This
blueprint describes how a European core curriculum in CPT
might look like but can be adapted to suit the local preferences of
medical schools, given the differences in institution’s culture and
resources.
METHODS
A Delphi study is a consensus method to determine the extent to which
experts agree about a given issue. This approach is often used when there
is a lack of scientific evidence or when there is contradictory evidence on
an issue, leading to a diversity of opinions.30,31 It has proven to be a suit-
able method for determining the content of a CPT curriculum.14,15,17
Figure 3 Blueprint of an integrated context-based European core curriculum in clinical pharmacology and therapeutics describing when and how learning
outcomes might be taught and assessed during the early (i.e., years 1–3 in Europe and years 1–2 in the USA) and later years (i.e., years 4–6 in Europe
and years 3–4 in the USA) of the medical curriculum. Journal clubs refer to discussing the scientific CPT literature in small groups of students in order to
teach critical appraisal skills. Case-based discussion groups involve discussing written patient cases in small groups of students together with a tutor.
Role-playing sessions refers to conducting therapeutic consultations with simulated patients. Pre-prescribing seminars involve medical students writing
instructions on in-patient drug charts, which have to be validated by a doctor before drugs are dispensed. Prescribing tutorials involve ward-based practi-
cal tutorials about common therapeutic problems and high-risk medicines for medical students during clinical attachments. Student-run clinics are real-
patient clinics designed to teach and train prescribing skills grounded in a real-life context and to provide students with early clinical experience and
responsibility under the supervision of a senior clinician. Workplace-based assessment entails direct observation of prescribing in clinical practice under
the supervision of a senior clinician. OSCE, objective structured clinical examination.
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The modified Delphi process took place between January and July 2017
and comprised the following: a systematic literature search; selection of a
European expert panel; and development of a web-based questionnaire
and its modification in two consecutive rounds followed by a face-to-
face meeting and final round. This modified Delphi process was adopted
to minimize time demands on the expert panel. Ethical approval for this
study was provided by the Dutch Ethics Review Board of Medical Edu-
cation (Approved Project no. NVMO-ERB 860).
Systematic literature search
With the assistance of a medical information specialist, we systemati-
cally searched three international databases (PubMed, EMBASE, and
ERIC) for articles describing CPT learning outcomes (i.e., knowledge,
skills and attitudes) in undergraduate medical curricula and published
up to 23 January 2017. Search terms included the following mesh
terms as well as a combination of free text words and mesh terms in
title or abstract: “Medical Student,” “Medical Graduate,” “Medical
Undergraduate,” “Medical Education,” “Curriculum,” “Drug Therapy,”
“Pharmacotherapy,” “Pharmacology,” “Prescriptions,” “Prescribing,”
“Competence,” “Expertise,” “Knowledge,” “Skills,” and “Attitudes.”
Articles were assessed independently for eligibility by two researchers
(D.B. and S.d.G.), based on a list of predefined inclusion and exclu-
sion criteria. Reference lists from included publications were also
screened to identify additional articles. Reviews, letters to the editor,
editorials, conference abstracts, symposium reports, and qualitative
studies were excluded. Also, studies were excluded if a specific educa-
tional intervention or teaching method was evaluated, the language
was different from English, German, or Dutch, or if the abstract or
full-text was not available. Based on articles identified in the literature
search (Table S2), specifically the article by Ross and Maxwell,13 the
steering committee extracted a list of 307 learning outcomes, divided
into 35 subcategories. The steering committee consisted of a clinical
pharmacologist, a junior doctor, an internist-infectious disease special-
ist, and a senior lecturer in prescribing.
European expert panel
We invited European experts in clinical pharmacology, pharmacy, and
medical education, as well as junior doctors and senior clinicians working
in primary and secondary care, to participate in a consensus panel.
Experts were selected from the EACPT Network of Teachers in Phar-
macotherapy (NOTIP), a European platform for CPT teachers that sup-
ports the development and sharing of teaching materials and
participation in joint research projects. Participants of previous research
projects of the EACPT Education Working Group were specifically
invited to participate.8,10 All experts had to be involved in developing or
delivering CPT education to students training in a health profession and
should have at least 3 years’ educational experience. Participants received
an e-mail containing information about the general objectives of the
study and instructions about the Delphi process. Participation was vol-
untary and informed consent was obtained from all participants.
Data collection and analysis
We developed a web-based questionnaire (using surveymonkey.com)
containing 307 key learning outcomes divided into three categories:
knowledge (n5 233), skills (n5 65), and attitudes (n5 9). Minor mod-
ifications to the content were made after a pilot study with seven Euro-
pean CPT teachers.
In the first round, panelists were asked to rate each outcome (15 very
unimportant, 25 unimportant, 35 neutral, 45 important, 55 very
important), indicating their agreement that the outcome should be
included in the undergraduate CPT curriculum and should be expected
of European graduates in order that they can prescribe safely and effec-
tively. If panelists awarded an outcome a score of 4 or 5, they were asked
to indicate whether that outcome should be acquired during the preclini-
cal (i.e., bachelor’s degree) or clinical (i.e., master’s degree, clerkships)
years of the curriculum, or both. Additionally, panelists could also
change the wording of outcomes and add new outcomes if they felt these
were missing. An outcome was included if 80% of the experts gave it a
score of 4 or 5. This cutoff is in line with a similar study14 and was cho-
sen in order to create a list of “need to know” learning outcomes rather
than one with “nice to know” outcomes.
In the second round, panelists were shown which outcomes did not
meet the 80% agreement cutoff in the first round, the additional sug-
gested outcomes, and the group score for each outcome. Panelists were
asked to reconsider each outcome based on the group opinion using the
same 5-point scale. They had the opportunity to justify their point of
view in an open text box. During these two rounds, panelists were anon-
ymous to other panelists and individual scores were confidential.
Panelists were invited to attend a 2-h face-to-face meeting during the
13th congress of the EACPT (www.eacpt2017.org). During this meeting,
panelists discussed the outcomes with 75–80% agreement after Round 2
and were asked to vote (yes, no, unsure) for acceptance, rejection, or
modification. Voting was anonymous via mobile devices. In the third
round, panelists were asked to rate outcomes that had been rephrased
during the panel meeting using the 5-point scale. A summary of the
arguments for and against changes was provided. Panelists were allowed
3 weeks to complete each questionnaire round; reminders were sent
after 1 and 2 weeks. After each round, responses were downloaded in
Excel format and analyzed descriptively using IBM SPSS v. 22.0
(Armonk, NY).
Additional Supporting Information may be found in the online version of
this article.
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